Back to
BNP Paribas Financial Markets
QNCX
Showing 6 of 27 quarters
Position history for
BNP Paribas Financial Markets's holdings in QUINCE THERAPEUTICS INC
As of its Q1 2026 13F, BNP Paribas Financial Markets held 8 shares of QNCX (Quince Therapeutics), worth $1. BNP Paribas Financial Markets' 13F filings listed QNCX from Q2 2025 to Q1 2026, 4 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History